DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20174150

Borderline ovarian tumours-patterns of recurrence and fertility outcome

Dhanya Dinesh, Rema Prabhakaran Nair, Suchetha Sambasivan, Aswin Kumar, Iqbal M. Ahamed

Abstract


Background: The aim of the study was to evaluate the factors affecting recurrence and prognosis in patients with borderline ovarian tumours and to assess the fertility outcome in women treated with conservative surgery.

Methods: Fifty-six patients diagnosed with borderline ovarian tumours during the period between January 2005 and December 2009 in Regional Cancer Centre (RCC), Thiruvananthapuram were included. Patients were followed till December 2012.

Results: Median follow up period was 52.5 months. The mean age at diagnosis was 33.5 yrs. Histopathology was serous in 41.1%, mucinous in 57.1%, and endometrioid in 1.8%. 48 patients (85.7%) had stage I disease, 2 patients (3.6%) had Stage II disease and 6 patients (10.7%) had stage III disease at diagnosis. 11 patients (19.6%) had bilateral tumours of which 7(63.6%) were serous and 4 were mucinous. 27 patients (48.2%) underwent fertility sparing surgery of which 13 patients underwent cystectomy and 14 underwent ovariotomy. 29 patients (51.78 %) underwent complete surgery including hysterectomy, bilateral salpingo oopherectomy and omentectomy. 14.3% of patients had microinvasive disease and 14.3 % had micro papillary disease on histopathology. 9 patients (16.1 %) had peritoneal implants of which 1 was invasive and 8 were non-invasive. Recurrence rate in the entire study group was 30.4%, 14.28% among patients undergoing complete surgery, 28.57% among patients undergoing adnexectomy and 69.2% among patients undergoing cystectomy.

Conclusions: Univariate analysis showed a significant association between micropapillary histology, peritoneal implants and recurrence. On multivariate analysis, only peritoneal implants were found to be independently associated with recurrence.


Keywords


Borderline ovarian tumours, Recurrence, Risk factors

Full Text:

PDF

References


Winter WE, Kucera PR, Rodgers W. Surgical staging in patients with ovarian tumours of low malignant potential. Obstet Gynecol. 2002:100:671-6.

Trimble CL, Kosary C, Trimble EL, Long term survival and patterns of care in women with ovarian tumours of low malignant potential, Gynecol Oncol. 2002;86:34-7.

Menzin AW, Gal D, Lovecchio JL, Contemporary surgical management of borderline ovarian tumours: a survery of the Society of Gynecologic Oncologists, Gynecol Oncol. 2007;78:7-9.

Jie Ren, Zhilan Peng, Kaixuan Yang. A clinicopathologic multivariate analysis affecting recurrence of borderline ovarian tumours. Gynecol Oncol. 110(2008)162-7.

Kennedy AW, Hart WR. Ovarian papillary serous tumours of low malignant potential (serous borderline tumours): a long term follow up study including patients with micro invasion, lymph node metastasis and transformation to invasive serous carcinoma. Cancer. 1996:78;278-86.

Link CJ, Reed E, Sarosy G, Kohn E. Borderline ovarian tumours. Am J Med. 1996;101:217-25.

Morice P, Camatte S, Wicart-Poque F, Atallah D, Rouzier R, Pautier P, et al. Results of conservative management of epithelial malignant and borderline ovarian tumours. Hum Reprod Update. 2003;9:185

Poncelet C, Fauvet R, Boccara J, Darai E. Recurrence after cystectomy for borderline ovarian tumours: Results of a French Multicenter study. Annals Surg Oncol. 2006;13(4):565-71.

Palomba S, Zupi E, Russo T, Falbo A, Negro SD, Manguso F, et al. Comparison of two fertility sparing approaches for bilateral borderline tumours; a randomized controlled study. Human Reproduction 2007;22:578-85.

Hogg R, Scurry J, Kim SN, Friedlander M, Hacker N. Microinvasion links ovarian serous borderline tumour and grade I invasive carcinoma. Gynecol Oncol. 2007;106:44-51.

Morris RT, Gershenson DM, Silva EG, Follen M, Morris M, Wharton JT. Outcome and reproductive function after conservative surgery for borderline ovarian tumours. Obstet Gynecol. 2009;95:541-7.

Smith Schdev AE, Schdev PS, Kurman RJ. Noninvasive and invasive micropapillary (low grade) serous carcinoma of the ovary; a clinicopathological analysis of 135 cases. Am J Surg Pathol. 2003;27:725-36.